title: Success and failure of vaccines against renin-angiotensin system components.
abstract: Therapeutic vaccination pre-dated modern drugs as a possible strategy for treating hypertension. This approach is now being rediscovered, through use of modified angiotensins as immunogens together with carriers and adjuvants. Effective blockade of the renin-angiotensin system (RAS) with treatment twice a year might suit patients who dislike taking drugs on a daily basis and would also be an attractive option for those who have blood pressures in the prehypertensive range, if it can prevent hypertension itself from developing. Proof of concept with a vaccine whose efficacy is easy to measure will encourage development of further vaccines directed against targets such as aldosterone or other pathways where alternative treatments are scarce or absent. Two angiotensin-based vaccines are currently in development: PMD3117 comprises modified angiotensin I coupled to keyhole limpet hemocyanin, and Cyt006-AngQb is a conjugate of angiotensin II linked to virus particles. Early phase II studies in patients with hypertension demonstrated some efficacy, but the vaccines are not as effective as existing inhibitors of the RAS. Large studies now in progress will establish whether further modification of the immunogen or adjuvant is required to boost antibody titers.
authors.affiliation: Clinical Pharmacology Unit, University of Cambridge, Cambridge, UK. mjb14@hermes.cam.ac.uk
authors.forename: Morris J
authors.initials: MJ
authors.lastname: Brown
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000906:Antibodies / Q000097:blood; D001794:Blood Pressure / Q000276:immunology*; D049673:History, 20th Century; D006801:Humans; D006973:Hypertension / Q000266:history / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control / Q000628:therapy*; D007115:Immunization Schedule; D009842:Oligopeptides / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000276:immunology*; D013997:Time Factors; D017211:Treatment Failure; D016896:Treatment Outcome; D014612:Vaccines / Q000008:administration & dosage / Q000266:history / Q000627:therapeutic use*
chemical_list: D000276:Adjuvants, Immunologic; D000906:Antibodies; C525491:CYT006-AngQb; D009842:Oligopeptides; D014612:Vaccines
references.citation: Hypertension. 2007 Jul;50(1):161-6
references.pmid: 17470717
references.citation: Hypertension. 1982 Mar-Apr;4(2):185-9
references.pmid: 7068178
references.citation: Lancet. 2005 Jan 15-21;365(9455):217-23
references.pmid: 15652604
references.citation: J Hum Hypertens. 2003 Feb;17(2):81-6
references.pmid: 12574784
references.citation: Clin Sci (Lond). 2004 Aug;107(2):145-7
references.pmid: 15104532
references.citation: Lancet. 2004 Jun 19;363(9426):2022-31
references.pmid: 15207952
references.citation: Hypertension. 2007 Apr;49(4):839-45
references.pmid: 17309946
references.citation: Lancet. 2008 Mar 8;371(9615):821-7
references.pmid: 18328929
references.citation: Heart. 2007 Sep;93(9):1026-33
references.pmid: 17488768
references.citation: Biol Chem. 2008 May;389(5):521-36
references.pmid: 18953718
references.citation: Lancet. 2006 May 27;367(9524):1747-57
references.pmid: 16731270
references.citation: JAMA. 2000 Apr 19;283(15):1967-75
references.pmid: 10789664
references.citation: Ann Pharmacother. 2005 Sep;39(9):1401-8
references.pmid: 16076920
references.citation: Clin Pharmacol Ther. 1999 Oct;66(4):367-73
references.pmid: 10546920
references.citation: Hypertension. 1999 Mar;33(3):850-5
references.pmid: 10082498
references.citation: Hypertension. 1990 Nov;16(5):564-72
references.pmid: 2172161
references.citation: Lancet. 1998 Jun 13;351(9118):1755-62
references.pmid: 9635947
references.citation: Lancet. 2002 Mar 23;359(9311):995-1003
references.pmid: 11937178
references.citation: J Biol Chem. 1976 Aug 25;251(16):4828-32
references.pmid: 182680
references.citation: J Hypertens. 2002 Aug;20(8):1461-4
references.pmid: 12172300
references.citation: J Hypertens. 2007 Jan;25(1):63-72
references.pmid: 17143175
references.citation: Lancet. 2005 Oct 8;366(9493):1267-78
references.pmid: 16214597
references.citation: Circulation. 2008 Aug 12;118(7):773-84
references.pmid: 18695203
references.citation: JAMA. 2002 Dec 18;288(23):2981-97
references.pmid: 12479763
references.citation: Science. 1971 Dec 24;174(4016):1344-6
references.pmid: 4332626
references.citation: Hypertension. 1993 Aug;22(2):139-46
references.pmid: 8340149
references.citation: Lancet. 2005 Sep 10-16;366(9489):895-906
references.pmid: 16154016
references.citation: Hypertension. 1990 Dec;16(6):603-14
references.pmid: 2246027
references.citation: J Allergy Clin Immunol. 2006 Jun;117(6):1470-6
references.pmid: 16751015
references.citation: Lancet. 2002 Dec 14;360(9349):1903-13
references.pmid: 12493255
references.citation: Am Heart J. 1989 Mar;117(3):756-67
references.pmid: 2537558
references.citation: Circulation. 1990 Jun;81(6):1899-910
references.pmid: 2188756
references.citation: Arch Intern Med. 2005 Jun 27;165(12):1410-9
references.pmid: 15983291
references.citation: Hypertension. 2002 Dec;40(6):892-6
references.pmid: 12468575
references.citation: Br J Pharmacol. 2000 Mar;129(6):1178-82
references.pmid: 10725266
references.citation: J Hypertens. 2007 May;25(5):951-8
references.pmid: 17414657
references.citation: World J Surg. 1998 Dec;22(12):1243-5
references.pmid: 9841751
references.citation: Trans Assoc Am Physicians. 1951;64:122-5
references.pmid: 14884242
references.citation: N Engl J Med. 2008 Apr 10;358(15):1547-59
references.pmid: 18378520
references.citation: Proc Natl Acad Sci U S A. 1987 Jun;84(12):4346-50
references.pmid: 3108891
references.citation: J Clin Invest. 1969 Aug;48(8):1506-18
references.pmid: 4307701
references.citation: Hypertension. 2001 Sep;38(3):439-43
references.pmid: 11566919
references.citation: Lancet. 2008 Sep 27;372(9644):1174-83
references.pmid: 18757085
references.citation: J Hypertens. 2003 Jun;21(6):1055-76
references.pmid: 12777939
references.citation: Circ Res. 1975 Nov;37(5):607-14
references.pmid: 1192557
references.citation: Lancet. 2007 Aug 18;370(9587):591-603
references.pmid: 17707755
references.citation: Lancet. 2003 Nov 8;362(9395):1527-35
references.pmid: 14615107
references.citation: N Engl J Med. 2008 Dec 4;359(23):2417-28
references.pmid: 19052124
references.citation: Clin Sci (Lond). 2004 Aug;107(2):167-73
references.pmid: 15040783
references.citation: Br J Clin Pharmacol. 2003 Nov;56(5):505-12
references.pmid: 14651724
references.citation: Intervirology. 2002;45(4-6):212-7
references.pmid: 12566703
references.citation: Hypertension. 2009 Mar;53(3):480-6
references.pmid: 19204180